Brussels-Sana
The European Union announced its readiness to help pharmaceutical companies produce a greater quantity of their vaccines against the Corona virus, to overcome the distribution crisis.
The German News Agency quoted the European Commissioner in charge of health, Stella Kyriakides, as saying in a statement today that the bloc is ready to do more for the benefit of the American companies Pfizer and German Piontech and other companies that have vaccines against the Corona virus with the start of the vaccination campaign, noting that any delay in obtaining approved vaccines is due to To lack of production capacity and not European planning.
Kyriakides added that the European Union provided support with 100 million euros to Biontech, which developed a vaccine in cooperation with Pfizer to help enhance production capabilities, stressing that the situation "will improve step by step" after a week of the start of vaccination campaigns in the countries of the European Union.
Kyriakides pointed out that if all vaccines were approved, Europe would have more than two billion doses available to 450 million Europeans and their neighbors, which would enable Europeans to get out of the crisis faster.
The European Medicines Agency, which advises the European Commission, approved the Pfizer Bionic vaccine on December 21, but it is not expected to license the American company Moderna before the sixth of January.